Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot crossover bioequivalence study of E3810 in healthy Japanese males
jRCT1080221228Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of lucitanib in Peptic ulcer disease (PUD) (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Primary pharmacokinetic endpoints.
02
Drugs
lucitanib
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT1080221228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221228.